Rischin D, Harrington KJ, Greil R, Soulieres D, et al. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048. Oral Oncol 2022;128:105815.
PMID: 35381576